SCHEMBL7140291

SCHEMBL7140291

CSCNC=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2092508 0.71
SCHEMBL19285934 0.71
SCHEMBL7483138 0.68
SCHEMBL5260118 0.67
SCHEMBL5652910 0.67
SCHEMBL5653358 0.66
SCHEMBL20156231 0.62
SCHEMBL26448 0.62
SCHEMBL633964 0.60
SCHEMBL3197403 0.60

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016116025-A1 JAK INHIBITOR 南京明德新药研发股份有限公司 2016-07-28 WO disclosed
CN-101360513-A Biodegradable and thermosensitive poly(organophosphazene) hydrogel, preparation method thereof and use thereof KOREA INST SCI & TECH (KR) 2009-02-04 CN disclosed
EP-1086124-B1 NOVEL CYCLOSPORINS CHEM AG C (CH) 2003-11-19 EP disclosed
US-6583265-B1 Compound for use in the prevention of viral and bacterial infections C-CHEM AG (CH) 2003-06-24 US disclosed
EP-1086124-A1 NOVEL CYCLOSPORINS C-Chem AG (CH) 2001-03-28 EP disclosed
WO-1999065933-A1 NOVEL CYCLOSPORINS C-CHEM AG (CH) 1999-12-23 WO disclosed